A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Clinical trial NCT05709444 · COMPLETED
Trial details
- NCT number
- NCT05709444
- Sponsor
- Palatin Technologies, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-26
- Primary completion
- 2024-04-26
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.